Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Bañas

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|January 16, 2009
Hepatitis B virus infectionJuan Miguel Bergua, Carmen Cabrera, Helena Bañas
British Journal of Haematology|January 20, 2007
Dose-adjusted EPOCH plus rituximab is an effective regimen in patients with poor-prognostic untreated diffuse large B-cell lymphoma: results from a prospective observational studyJulio García-Suárez, Helena Bañas, Ignacio Arribas, et al.
American Journal of Hematology|November 30, 2005
Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapiesJulio García-Suárez, Dunia de Miguel, Isabel Krsnik, et al.
Diagnostic Microbiology and Infectious Disease|July 5, 2005
Nonfatal pulmonary Trichoderma viride infection in an adult patient with acute myeloid leukemia: report of one case and review of the literatureDunia De Miguel, Peña Gómez, Rosa González, et al.
Frontiers in Immunology|August 22, 2017
<i>In Vitro</i> Culture with Interleukin-15 Leads to Expression of Activating Receptors and Recovery of Natural Killer Cell Function in Acute Myeloid Leukemia PatientsBeatriz Sanchez-Correa, Juan M Bergua, Alejandra Pera, et al.
Cytokine|January 30, 2013
Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levelsBeatriz Sanchez-Correa, Juan M Bergua, Carmen Campos, et al.
Cancer Immunology, Immunotherapy : CII|June 11, 2015
Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?Beatriz Sanchez-Correa, Carmen Campos, Alejandra Pera, et al.
Cancers|June 26, 2019
DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer ImmunotherapyBeatriz Sanchez-Correa, Isabel Valhondo, Fakhri Hassouneh, et al.
Cancer Immunology, Immunotherapy : CII|August 18, 2016
Immunosenescence: limitations of natural killer cell-based cancer immunotherapyRaquel Tarazona, Beatriz Sanchez-Correa, Ignacio Casas-Avilés, et al.
Cancers|August 9, 2020
Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid LeukemiaIsabel Valhondo, Fakhri Hassouneh, Nelson Lopez-Sejas, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|January 16, 2009
Hepatitis B virus infectionJuan Miguel Bergua, Carmen Cabrera, Helena Bañas
British Journal of Haematology|January 20, 2007
Dose-adjusted EPOCH plus rituximab is an effective regimen in patients with poor-prognostic untreated diffuse large B-cell lymphoma: results from a prospective observational studyJulio García-Suárez, Helena Bañas, Ignacio Arribas, et al.
American Journal of Hematology|November 30, 2005
Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapiesJulio García-Suárez, Dunia de Miguel, Isabel Krsnik, et al.
Diagnostic Microbiology and Infectious Disease|July 5, 2005
Nonfatal pulmonary Trichoderma viride infection in an adult patient with acute myeloid leukemia: report of one case and review of the literatureDunia De Miguel, Peña Gómez, Rosa González, et al.
Frontiers in Immunology|August 22, 2017
<i>In Vitro</i> Culture with Interleukin-15 Leads to Expression of Activating Receptors and Recovery of Natural Killer Cell Function in Acute Myeloid Leukemia PatientsBeatriz Sanchez-Correa, Juan M Bergua, Alejandra Pera, et al.
Cytokine|January 30, 2013
Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levelsBeatriz Sanchez-Correa, Juan M Bergua, Carmen Campos, et al.
Cancer Immunology, Immunotherapy : CII|June 11, 2015
Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?Beatriz Sanchez-Correa, Carmen Campos, Alejandra Pera, et al.
Cancers|June 26, 2019
DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer ImmunotherapyBeatriz Sanchez-Correa, Isabel Valhondo, Fakhri Hassouneh, et al.
Cancer Immunology, Immunotherapy : CII|August 18, 2016
Immunosenescence: limitations of natural killer cell-based cancer immunotherapyRaquel Tarazona, Beatriz Sanchez-Correa, Ignacio Casas-Avilés, et al.
Cancers|August 9, 2020
Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid LeukemiaIsabel Valhondo, Fakhri Hassouneh, Nelson Lopez-Sejas, et al.
Pageof 2